Home > Boards > US Listed > Medical - Drugs > AstraZeneca PLC (AZN)

AZN buy 40.92

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stocktrademan Member Profile
 
Followed By 457
Posts 9,985
Boards Moderated 1
Alias Born 04/28/14
160x600 placeholder
GSK, AstraZeneca Partner to Tackle Covid-19 Test Shortages Dow Jones News - 4/7/2020 9:30:00 AM
RedHill Biopharma ADRs Up; Completes Movantik Acquisition Dow Jones News - 4/2/2020 12:25:00 PM
BRILINTA reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial Business Wire - 3/30/2020 9:16:00 AM
FARXIGA Phase III DAPA-CKD Trial Will Be Stopped Early After Overwhelming Efficacy in Patients With Chronic Kidney Disease Business Wire - 3/30/2020 7:05:00 AM
IMFINZI (durvalumab) Approved in the US for Extensive-Stage Small Cell Lung Cancer Business Wire - 3/30/2020 7:00:00 AM
AstraZeneca Stops Farxiga Trials Early Due to Overwhelming Efficacy Dow Jones News - 3/30/2020 2:53:00 AM
FARXIGA reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DA... Business Wire - 3/28/2020 9:53:00 AM
Silence Therapeutics Gets $80 Million Investment From AstraZeneca; Shares Surge Dow Jones News - 3/25/2020 5:06:00 AM
Bellus Health to Acquire Remaining BLU-5937 Rights Dow Jones News - 3/23/2020 8:27:00 AM
Insmed: AstraZeneca Exercises Exclusive Option to Advance INS1007 Dow Jones News - 3/16/2020 5:36:00 PM
AstraZeneca Cediranib Phase 3 Trial Didn't Meet Endpoint Dow Jones News - 3/12/2020 3:59:00 AM
First Patient Dosed in IPH5201 Phase I Clinical Trial in Advanced Solid Tumors GlobeNewswire Inc. - 3/10/2020 2:00:10 AM
AstraZeneca Phase III DANUBE Trial in Bladder Cancer Didn't Meet End Point Dow Jones News - 3/6/2020 2:44:00 AM
AbbVie Buy of Allergan Passes Muster in Europe, But U.S. Review Continues Dow Jones News - 3/3/2020 9:07:00 AM
Big Drugmakers Warn About Coronavirus Impact on Business Dow Jones News - 3/1/2020 11:29:00 AM
AstraZeneca to Sublicense Global Rights to Movantik to RedHill Biopharma Dow Jones News - 2/25/2020 2:41:00 AM
NeoTX Closes $45 Million Series C Financing GlobeNewswire Inc. - 2/19/2020 3:00:10 AM
AstraZeneca 4Q Core Operating Profit Tumbled, Expects Growth in 2020 Dow Jones News - 2/14/2020 3:03:00 AM
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney D... GlobeNewswire Inc. - 2/11/2020 5:00:10 PM
Educational Lung Cancer Event Coming to The Villages to Raise Awareness of the State’s High Rate of Lung Cancer Business Wire - 1/30/2020 9:00:00 AM
BRILINTA Met Primary Endpoint in the Phase III THALES Trial in Stroke Business Wire - 1/27/2020 7:00:00 AM
AstraZeneca: Enhertu Phase 2 Trial Meets Primary Endpoint Dow Jones News - 1/27/2020 2:58:00 AM
AstraZeneca's Brilinta Met Primary Endpoint in Phase Three Stroke Trial Dow Jones News - 1/27/2020 2:54:00 AM
AstraZeneca to Recover Global Rights to Brazikumab From Allergan Dow Jones News - 1/27/2020 2:48:00 AM
AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep PR Newswire (US) - 1/27/2020 1:15:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist